FUS and breast carcinoma: Analysis of the data from Metabric and The Cancer Genome Atlas (TCGA) databases revealed that FUS expression levels were significantly higher in breast cancer tissues than in normal tissues, suggesting its potential as an oncogene in breast cancer (Figure 2D; Figure S1C, Supporting Information).